Company Filing History:
Years Active: 2022
Title: Innovations in Immunotherapy by Daniel Stephen Wilkinson
Introduction
Daniel Stephen Wilkinson is an accomplished inventor based in Charlotte, NC (US). He has made significant contributions to the field of immunotherapy, particularly in the cultivation and expansion of regulatory T cells. His work has the potential to impact treatments for autoimmune diseases, metabolic disorders, and chronic inflammatory conditions.
Latest Patents
Wilkinson holds a patent titled "Compositions and methods for in vitro cultivation and/or expansion of regulatory T cells." This invention focuses on the maintenance and expansion of stable FOXP3 regulatory T cell lines. The insights gained from this research can enhance our understanding of FOXP3 Treg physiology and facilitate the development of effective Treg-based immunotherapy strategies. He has 1 patent to his name.
Career Highlights
Wilkinson is affiliated with East Carolina University, where he continues to advance his research in immunotherapy. His work is crucial in exploring new therapeutic avenues for various chronic diseases.
Collaborations
One of his notable collaborators is Mark David Mannie, with whom he has worked on various projects related to T cell research.
Conclusion
Daniel Stephen Wilkinson's innovative work in the field of immunotherapy exemplifies the potential of regulatory T cells in treating complex diseases. His contributions are paving the way for future advancements in medical therapies.